Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2016-12-12 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ECHIROLLES (38130), Isere
PHARMACIE DE LA PONATIERE : revenue, balance sheet and financial ratios
PHARMACIE DE LA PONATIERE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ECHIROLLES (38130),
this company of category PME
shows in 2023 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PONATIERE (SIREN 824369474)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
1 699 627 €
N/C
N/C
N/C
N/C
1 661 107 €
Net income
109 793 €
67 324 €
85 845 €
199 304 €
89 908 €
86 941 €
82 906 €
49 916 €
EBITDA
N/C
N/C
128 886 €
N/C
N/C
N/C
N/C
83 834 €
Net margin
N/C
N/C
5.1%
N/C
N/C
N/C
N/C
3.0%
Revenue and income statement
In 2025, PHARMACIE DE LA PONATIERE generates positive net income of 110 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 50 k€ -> 110 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
109 793 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
19.793%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.532%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA PONATIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
599.323
333.114
193.535
132.069
62.587
43.611
34.814
19.793
Financial autonomy
10.753
17.691
27.744
35.499
49.919
57.382
56.618
63.532
Repayment capacity
9.827
None
None
None
None
2.703
None
None
Cash flow / Revenue
4.035%
None%
None%
None%
None%
5.84%
None%
None%
Sector positioning
Debt ratio
19.792025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-8 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA PONATIERE (19.79) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.53%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DE LA PONATIERE (63.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
2.7 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE DE LA PONATIERE (2.70) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 186.24. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
186.237
Liquidity indicators evolution PHARMACIE DE LA PONATIERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
145.945
164.418
188.086
215.287
228.633
221.33
179.879
186.237
Interest coverage
9.367
None
None
None
None
2.409
None
None
Sector positioning
Liquidity ratio
186.242025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good-8 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA PONATIERE (186.24) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.41x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE LA PONATIERE (2.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PONATIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
140 397 €
0 €
0 €
0 €
0 €
223 807 €
0 €
0 €
Inventory turnover (days)
24
0
0
0
0
30
0
0
Customer payment term (days)
7
0
0
0
0
7
0
0
Supplier payment term (days)
55
0
0
0
0
43
0
0
Positioning of PHARMACIE DE LA PONATIERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA PONATIERE is estimated at
1 744 074 €
(range 1 183 537€ - 2 736 693€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1183k€1744k€2736k€
1 744 074 €Range: 1 183 537€ - 2 736 693€
NAF 5 année 2025
Valuation method used
Net Income Multiple
109 793 €
×
15.9x
=1 744 075 €
Range: 1 183 537€ - 2 736 694€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PONATIERE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PONATIERE
What is the revenue of PHARMACIE DE LA PONATIERE ?
The revenue of PHARMACIE DE LA PONATIERE in 2023 is 1.7 M€.
Is PHARMACIE DE LA PONATIERE profitable?
Yes, PHARMACIE DE LA PONATIERE generated a net profit of 110 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA PONATIERE ?
The headquarters of PHARMACIE DE LA PONATIERE is located in ECHIROLLES (38130), in the department Isere.
Where to find the tax return of PHARMACIE DE LA PONATIERE ?
The tax return of PHARMACIE DE LA PONATIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PONATIERE operate?
PHARMACIE DE LA PONATIERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart